Racing regulators in New York are poised to enact new threshold levels for 24 equine drugs as well as propose rules to regulate shock wave and similar therapy on Thoroughbred racehorses.

The latter regulations mirror existing policies by the New York Racing Association, the New York State Gaming Commission (NYSGC) said Nov. 4. The commission’s new drug rules will be run by the industry in a series of meetings, including a public hearing, in December or early January.

Most of the 24 drugs, identified by the Racing Medication and Testing Consortium, are seen as therapeutic in nature as opposed to performance-enhancing. The rules augment New York’s "time-based” drug rules that prohibit certain drugs from being in a horse’s urine or blood within a certain period of time before a race.

Now, the NYSGC wants to set precise levels, above which the presence of any of the 24 drugs would be considered a violation of the rules